Management of chronic obstructive pulmonary disease

• Autor(a) principal: Cunha, Ana S.
• Data de Publicação: 2024
• Outros Autores: Raposo, Beatriz, Dias, Filipe, Henriques, Susana, Martinho, Hugo, Pedro, Ana R.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
• Texto Completo: http://hdl.handle.net/10362/167126
• topic: Chronic obstructive pulmonary disease; Delphi technique; Disease management; Health services accessibility; Health Policy; Public Health, Environmental and Occupational Health; SDG 3 - Good Health and Well-being

Funding Information: This work has been supported by AstraZeneca Produtos Farmacêuticos Lda., a pharmaceutical company with a direct interest in COPD. However, AstraZeneca had no direct role in study design, data collection, and analysis or preparation of the manuscript. AstraZeneca Produtos Farmacêuticos Lda. has approved the decision to publish this work. A.S.C., B.R., F.D., and A.R.P. acknowledge the support of the NOVA National School of Public Health research and report no specific competing interests relevant to the submitted research. H.M. and S.H. are employees of AstraZeneca Produtos Farmacêuticos Lda. and report no other specific competing interests relevant to the research presented in this article. They have in place an approved plan for managing potential conflicts of interest arising from their involvement in scientific research. Funding Information: This study was funded by AstraZeneca Produtos Farmacêuticos Lda. Publisher Copyright: © 2024 S. Karger AG. All rights reserved.